Ryman Healthcare's 21% fall after resuming trading brings NZX 50 down 1.8%

Ryman Healthcare's 21% fall after resuming trading brings NZX 50 down 1.8%
The market isn’t pulling any punches, say analysts. (Image: NZME)
Gregor Thompson
Ryman Healthcare is under the spotlight for the second day running as it plummeted nearly 20% and brought the New Zealand benchmark down with it.The S&P/NZX 50 Index closed at 12,307, down 224.45 points or 1.79% on Tuesday. Across the whole market, there were 27 gainers and 108 decliners, with 53.9 million shares worth $230.8m changing hands. The index’s fall followed a 1.7% loss on Monday, extending the decline in February to more than 5%.Craigs Investment Partners research analyst Mohandeep Singh said recent weeks of trading ha...

More Markets

Vulcan Steel leads as reporting season approaches
Markets Market Close

Vulcan Steel leads as reporting season approaches

The S&P/NZX 50 Index closed 55.30 points higher at 12,889.38.

Jamie Gray 15 Aug 2025
Competition law changing to allow 'beneficial collaboration'
Markets

Competition law changing to allow 'beneficial collaboration'

Confidential submissions to the Commerce Commission will get a 10-year OIA exemption.

Pattrick Smellie 15 Aug 2025
Small cap spotlight: Blackpearl Group
Markets Small Cap Wrap

Small cap spotlight: Blackpearl Group

Founder Nick Lissette says it's patriotic to be listed, but hard work.

NZ sharemarket rises, Vista Group shares fall
Markets Market Close

NZ sharemarket rises, Vista Group shares fall

The New Zealand sharemarket was up on Thursday as most stocks on the main board lifted.

Tom Raynel 14 Aug 2025